|
1
|
King TE Jr, Pardo A and Selman M:
Idiopathic pulmonary fibrosis. Lancet. 378:1949–1961. 2011.
View Article : Google Scholar
|
|
2
|
Selman M, Thannickal VJ, Pardo A, Zisman
DA, Martinez FJ and Lynch JP III: Idiopathic pulmonary fibrosis:
pathogenesis and therapeutic approaches. Drugs. 64:405–430. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Phan SH: Biology of fibroblasts and
myofibroblasts. Proc Am Thorac Soc. 5:334–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee K and Nelson CM: New insights into the
regulation of epithelial-mesenchymal transition and tissue
fibrosis. Int Rev Cell Mol Biol. 294:171–221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coward WR, Saini G and Jenkins G: The
pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis.
4:367–388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gharaee-Kermani M, Hu B, Phan SH and
Gyetko MR: Recent advances in molecular targets and treatment of
idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the
myofibroblast. Curr Med Chem. 16:1400–1417. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chapman HA: Epithelial-mesenchymal
interactions in pulmonary fibrosis. Annu Rev Physiol. 73:413–435.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
the importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lan HY and Chung AC: Transforming growth
factor-beta and Smads. Contrib Nephrol. 170:75–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pohlers D, Brenmoehl J, Loffler I, Müller
CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW and Wolf G:
TGF-beta and fibrosis in different organs - molecular pathway
imprints. Biochim Biophys Acta. 1792:746–756. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Willis BC, Liebler JM, Luby-Phelps K,
Nicholson AG, Crandall ED, du Bois RM and Borok Z: Induction of
epithelial-mesenchymal transition in alveolar epithelial cells by
transforming growth factor-beta1: potential role in idiopathic
pulmonary fibrosis. Am J Pathol. 166:1321–1332. 2005. View Article : Google Scholar
|
|
15
|
Kasai H, Allen JT, Mason RM, Kamimura T
and Zhang Z: TGF-beta1 induces human alveolar epithelial to
mesenchymal cell transition (EMT). Respir Res. 6:562005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fragiadaki M and Mason RM:
Epithelial-mesenchymal transition in renal fibrosis - evidence for
and against. Int J Exp Pathol. 92:143–150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
American Thoracic Society; European
Respiratory Society. American Thoracic Society/European Respiratory
Society International Multidisciplinary Consensus Classification of
the Idiopathic Interstitial Pneumonias. This joint statement of the
American Thoracic Society (ATS), and the European Respiratory
Society (ERS) was adopted by the ATS board of directors, June 2001
and by the ERS Executive Committee, June 2001. Am J Respir Crit
Care Med. 165:277–304. 2002.
|
|
18
|
Hutchison N, Hendry BM and Sharpe CC: Rho
isoforms have distinct and specific functions in the process of
epithelial to mesenchymal transition in renal proximal tubular
cells. Cell Signal. 21:1522–1531. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lv ZM, Wang Q, Wan Q, Lin JG, Hu MS, Liu
YX and Wang R: The role of the p38 MAPK signaling pathway in high
glucose-induced epithelial-mesenchymal transition of cultured human
renal tubular epithelial cells. PLoS One. 6:e228062011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kolosova I, Nethery D and Kern JA: Role of
Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal
transition of pulmonary epithelial cells. J Cell Physiol.
226:1248–1254. 2011.
|
|
21
|
van der Velden JL, Guala AS, Leggett SE,
Sluimer J, Badura EC and Janssen-Heininger YM: Induction of a
mesenchymal expression program in lung epithelial cells by wingless
protein (Wnt)/β-catenin requires the presence of c-Jun N-terminal
kinase-1 (JNK1). Am J Respir Cell Mol Biol. 47:306–314.
2012.PubMed/NCBI
|
|
22
|
Selman M, Pardo A and Kaminski N:
Idiopathic pulmonary fibrosis: aberrant recapitulation of
developmental programs? PLoS Med. 5:e622008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lomas NJ, Watts KL, Akram KM, Forsyth NR
and Spiteri MA: Idiopathic pulmonary fibrosis: immunohistochemical
analysis provides fresh insights into lung tissue remodelling with
implications for novel prognostic markers. Int J Clin Exp Pathol.
5:58–71. 2012.
|
|
24
|
Yamada M, Kuwano K, Maeyama T, Hamada N,
Yoshimi M, Nakanishi Y and Kasper M: Dual-immunohistochemistry
provides little evidence for epithelial-mesenchymal transition in
pulmonary fibrosis. Histochem Cell Biol. 129:453–462. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang M, Zhang Z, Pan HY, Wang DX, Deng ZT
and Ye XL: TGF-beta1 induces human bronchial epithelial
cell-to-mesenchymal transition in vitro. Lung. 187:187–194. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim JH, Jang YS, Eom KS, Hwang YI, Kang
HR, Jang SH, Kim CH, Park YB, Lee MG, Hyun IG, Jung KS and Kim DG:
Transforming growth factor beta1 induces epithelial-to-mesenchymal
transition of A549 cells. J Korean Med Sci. 22:898–904. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fernando RI, Castillo MD, Litzinger M,
Hamilton DH and Palena C: IL-8 signaling plays a critical role in
the epithelial-mesenchymal transition of human carcinoma cells.
Cancer Res. 71:5296–5306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Das S, Becker BN, Hoffmann FM and Mertz
JE: Complete reversal of epithelial to mesenchymal transition
requires inhibition of both ZEB expression and the Rho pathway. BMC
Cell Biol. 10:942009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ramos C, Becerril C, Montano M,
Garcia-De-Alba C, Ramirez R, Checa M, Pardo A and Selman M: FGF-1
reverts epithelial-mesenchymal transition induced by TGF-{beta}1
through MAPK/ERK kinase pathway. Am J Physiol Lung Cell Mol
Physiol. 299:L222–L231. 2010.PubMed/NCBI
|
|
30
|
Dudas PL, Argentieri RL and Farrell FX:
BMP-7 fails to attenuate TGF-beta1-induced
epithelial-to-mesenchymal transition in human proximal tubule
epithelial cells. Nephrol Dial Transplant. 24:1406–1416. 2009.
View Article : Google Scholar : PubMed/NCBI
|
